Shockwave Medical Inc 's ROA from the first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Shockwave Medical Inc 's ROA in the first quarter of 2024?
Shockwave Medical Inc achieved a return on average assets (ROA) of 12.91 % in its first quarter of 2024, this is above SWAV's average return on assets of 0.76%.
Shockwave Medical Inc assets over the 12 months ending in its first quarter of 2024 are valued at $1,267 million

ROA fell compared to the fourth quarter of 2023, despite the net income growth of 24.92% from the fourth quarter of 2023.

However, within the Healthcare sector 66 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2024 quarter, so far to 500, from total ROA ranking in the fourth quarter of 2023 at 536.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Total Assets Change	95.64 %	127.27 %	187.11 %	66.65 %	110.61 %
Y / Y Net Income Change	41.46 %	-68.56 %	-0.05 %	12.91 %	169.44 %
Net Income (TTM) in million	163	147	244	244	241
Return On Assets (TTM)	12.91 %	13.65 %	27.92 %	37.48 %	41.4 %
SWAV's Total Ranking	# 500	# 536	# 158	# 108	# 101
Total Assets (TTM) in million	1,535	1,470	1,367	695	785
Seq. Total Assets Change	4.4 %	7.56 %	96.63 %	-11.39 %	21.28 %
Seq. Net Income Change	24.92 %	26.64 %	21.22 %	-26.23 %	-72.23 %

SWAV's 5 Years Annual ROA >> Back to SWAV Management Effectiveness >> Compare SWAV ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 20
Sector	# 67
Overall	# 492

Return On Assets Statistics
High	Average	Low
45.2 %	0.76 %	-30.97 %
(Dec 31 2022)		(Mar 31 2020)

Financial Statements
Shockwave Medical Inc 's Assets	$ 1,535 million	SWAV's Balance sheet
Shockwave Medical Inc 's Income	$ 55 million	Quarterly SWAV's Income Statement
SWAV's Income by Division		See SWAV's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019
Y / Y Total Assets Change	127.27 %	87.15 %	27.07 %	17.29 %	-
Total Assets in million	1,470	647	346	272	232
Y / Y Net Income Change	-31.81 %	-	-	-	-
Net Income in million	147	216	-9	-66	-51
Annual Return On Assets	10.02 %	33.39 %	-2.64 %	-24.15 %	-22.04 %

SWAV's 5 Years Annual ROA >> Back to SWAV Management Effectiveness >> Compare SWAV ROA to its Competitors

Comment on SWAV's ROA in the fiscal year ending 2023

In the fiscal year 2023 Shockwave Medical Inc 's ROA decreased compared to previous year to 10.02 %, due to deterioration of net income -31.81 % to $147.28 million, from $216.00 million a year ago, as SWAV's assets were $1,470.25 million.

More Return On Assets Ratios
SWAV's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SWAV's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SWAV's Competitors
Subscribers only: Roa for Shockwave Medical Inc 's Suppliers
Subscribers only: Return On Assets for SWAV's Customers

You may also want to know
SWAV's Roi	SWAV's Inventory Turnover Ratio	SWAV's Growth Rates	SWAV's Dividend Comparisons
	SWAV's Profitability Ratios	SWAV's Asset Turnover Ratio	SWAV's Dividend Growth
SWAV's Roe	SWAV's Valuation Ratios	SWAV's Financial Strength Ratios	SWAV's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2024, within Healthcare Sector	ROA
Elite Pharmaceuticals Inc	33.27 %
Star Equity Holdings Inc	30.59 %
Lantheus Holdings Inc	29.05 %
Lite Strategy Inc	28.13 %
Idexx Laboratories Inc	27.57 %
Semler Scientific inc	27.38 %
Earth Science Tech Inc	25.07 %
Nrc Health	24.43 %
Alaunos Therapeutics Inc	23.92 %
Mettler toledo International Inc	23.40 %
Johnson and Johnson	22.07 %
Arcutis Biotherapeutics Inc	21.39 %
Iradimed Corporation	20.54 %
Alkermes Plc	19.91 %
Medpace Holdings Inc	19.70 %
Corcept Therapeutics Inc	19.57 %
Vertex Pharmaceuticals Inc	18.12 %
Chemed Corporation	17.54 %
Halozyme Therapeutics Inc	17.52 %
Harmony Biosciences Holdings inc	17.23 %
Tracon Pharmaceuticals Inc	17.03 %
Zoetis Inc	16.91 %
Spero Therapeutics Inc	16.83 %
Camp4 Therapeutics Corporation	16.15 %
Exelixis Inc	15.63 %
United Therapeutics Corporation	15.35 %
West Pharmaceutical Services Inc	15.31 %
Kewaunee Scientific Corporation	15.24 %
Innoviva Inc	15.06 %
Edwards Lifesciences Corporation	15.05 %

Date modified: 2026-09-08T15:11:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.